Perfusión de grandes dosis de insulina hacia arteria central de la retina

Tesis (Maestría en Ciencias) UANL

Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.

Critical limb ischemia in diabetic patients is associated with high rates of morbidity and mortality. Suboptimal responses to the available medical and surgical treatments are common in these patients, who also demonstrate limited vascular homeostasis. Neovasculogenesis induced by stem cell therapy could be a useful approach for these patients. Neovasculogenesis and clinical improvement were compared at baseline and at 3 and 12 months after autologous bone marrow-derived mononuclear cell (BMMNC) transplantation in diabetic patients with peripheral artery disease. We conducted a prospective study to evaluate the safety and efficacy of intra-arterial administration of autologous BMMNCs (100-400 × 10(6) cells) in 20 diabetic patients with severe below-the-knee arterial ischemia. Although the time course of clinical effects differed among patients, after 12 months of follow-up all patients presented a notable improvement in the Rutherford-Becker classification, the University of Texas diabetic wound scales, and the Ankle-Brachial Index in the target limb. The clinical outcome was consistent with neovasculogenesis, which was assessed at 3 months by digital subtraction angiography and quantified by MetaMorph software. Unfortunately, local cell therapy in the target limb had no beneficial effect on the high mortality rate in these patients. In diabetic patients with critical limb ischemia, intra-arterial perfusion of BMMNCs is a safe procedure that generates a significant increase in the vascular network in ischemic areas and promotes remarkable clinical improvement.

Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.

Critical limb ischemia in diabetic patients is associated with high rates of morbidity and mortality. Suboptimal responses to the available medical and surgical treatments are common in these patients, who also demonstrate limited vascular homeostasis. Neovasculogenesis induced by stem cell therapy could be a useful approach for these patients. Neovasculogenesis and clinical improvement were compared at baseline and at 3 and 12 months after autologous bone marrow-derived mononuclear cell (BMMNC) transplantation in diabetic patients with peripheral artery disease. We conducted a prospective study to evaluate the safety and efficacy of intra-arterial administration of autologous BMMNCs (100-400 × 10(6) cells) in 20 diabetic patients with severe below-the-knee arterial ischemia. Although the time course of clinical effects differed among patients, after 12 months of follow-up all patients presented a notable improvement in the Rutherford-Becker classification, the University of Texas diabetic wound scales, and the Ankle-Brachial Index in the target limb. The clinical outcome was consistent with neovasculogenesis, which was assessed at 3 months by digital subtraction angiography and quantified by MetaMorph software. Unfortunately, local cell therapy in the target limb had no beneficial effect on the high mortality rate in these patients. In diabetic patients with critical limb ischemia, intra-arterial perfusion of BMMNCs is a safe procedure that generates a significant increase in the vascular network in ischemic areas and promotes remarkable clinical improvement.

Determinación precoz de nefropatía diabética en base a parametros de laboratorio

Es importante diagnosticar tempranamente la afección renal y prevenir las alteraciones a nivel microvascular, para lo cual hemos tomado en consideración la determinación de la nicroalbuminuria, los niveles sanguíneos de fibrinógeno cuya elevación es considerada como factor de riesgo de la nefropatía. Los parámetros de control glucémico generados por la hemoglobina glicosilada y la fructosamina constituyen hasta hoy el mejor método para el control del metabolismo de los carboidratos, forman parte de nuestros objetivos, determinar sus valores. En nuestro estudio el 52 por ciento de la población estudiada presenta microalbuminuria basal positiva. El 70 por ciento de los investigados presenta un control dentro de parámetros normales, sin embargo el 52 por ciento de los pacientes con DM, a pesar de este buen control, presentan nofropatía irreversible. Del total de nefrópatas [52 por ciento], el 29 por ciento de los pacientes son del sexo femenino el 23 por ciento son del sexo masculino. Se observó que los años de evolución de la biabetes, tienen especial importancia en cuanto a la producción de la nefropatía, del 100 por cien de pacientes nefrópatas el 58 por ciento tenía entre 5 y 14 años de haber sido diagnosticado de diabetes.